{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T00:38:28Z","timestamp":1772757508408,"version":"3.50.1"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2010,1,6]],"date-time":"2010-01-06T00:00:00Z","timestamp":1262736000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Amino Acids"],"published-print":{"date-parts":[[2011,11]]},"DOI":"10.1007\/s00726-009-0439-0","type":"journal-article","created":{"date-parts":[[2010,1,5]],"date-time":"2010-01-05T10:31:19Z","timestamp":1262687479000},"page":"1059-1070","source":"Crossref","is-referenced-by-count":26,"title":["Impact of bifunctional chelators on biological properties of 111In-labeled cyclic peptide RGD dimers"],"prefix":"10.1007","volume":"41","author":[{"given":"Jiyun","family":"Shi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Young-Seung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sudipta","family":"Chakraborty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,1,6]]},"reference":[{"key":"439_CR1","first-page":"485","volume":"45","author":"L Aloj","year":"2004","unstructured":"Aloj L, Cacraco C, Panico M, Zannetti A, Del Vecchio S, Tesauro D, De Luca S, Arra C, Pedone C, Morelli G, Salvatore M (2004) In vitro and in vivo evaluation of 111In-DTPAGlu-G-CCK8 for cholecystokinin-B-receptor imaging. J Nucl Med 45:485\u2013494","journal-title":"J Nucl Med"},{"key":"439_CR2","first-page":"57","volume":"16","author":"A Ando","year":"1989","unstructured":"Ando A, Ando I, Hiraki T, Hishada K (1989) Relation between the location of the elements in the periodic table and various organ uptake rates. Nucl Med Biol 16:57\u201380","journal-title":"Nucl Med Biol"},{"key":"439_CR3","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1016\/0024-3205(91)90052-D","volume":"49","author":"WH Bakker","year":"1991","unstructured":"Bakker WH, Albert R, Bruns C, Breeman WA, Hofland LJ, Marbach P, Pless J, Pralet D, Stolz B, Koper JW, Lamberts SWJ, Visser TJ, Krenning EP (1991) [111In-DTPA-D-Phe1]-octreotide, a potential radiopharmaceutical for imaging of somatostatin receptor-positive tumors: synthesis, radiolabeling and in vitro validation. Life Sci 49:1583\u20131591","journal-title":"Life Sci"},{"key":"439_CR4","first-page":"1333","volume":"46","author":"AJ Beer","year":"2005","unstructured":"Beer AJ, Haubner R, Goebel M, Luderschmidt S, Spilker ME, Wester HJ, Weber WA, Schwaiger M (2005) Biodistribution and pharmacokinetics of the \u03b1v\u03b23-selective tracer 18F-Galacto-RGD in cancer patients. J Nucl Med 46:1333\u20131341","journal-title":"J Nucl Med"},{"key":"439_CR5","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1007\/s00259-004-1571-4","volume":"31","author":"L Bodei","year":"2004","unstructured":"Bodei L, Cremonesi M, Grana C, Rocca P, Bartolomei M, Chinol M, Paganelli G (2004) Receptor radionuclide therapy with 90Y-[DOTA]0-Tyr3-octreotide (90Y-DOTATOC) in neuroendocrine tumors. Eur J Nucl Med Mol Imaging 31:1038\u20131046","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"439_CR6","doi-asserted-by":"crossref","first-page":"227","DOI":"10.2174\/138955706775475975","volume":"6","author":"X Chen","year":"2006","unstructured":"Chen X (2006) Multimodality imaging of tumor integrin \u03b1v\u03b23 expression. Mini Rev Med Chem 6:227\u2013234","journal-title":"Mini Rev Med Chem"},{"key":"439_CR7","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.mibio.2004.06.004","volume":"6","author":"X Chen","year":"2004","unstructured":"Chen X, Liu S, Hou Y, Tohme M, Park R, Bading JR, Conti PS (2004a) MicroPET imaging of breast cancer \u03b1v-integrin expression with 64Cu-labeled dimeric RGD peptides. Mol Imaging Biol 6:350\u2013359","journal-title":"Mol Imaging Biol"},{"key":"439_CR8","first-page":"1390","volume":"45","author":"X Chen","year":"2004","unstructured":"Chen X, Park R, Hou Y, Tohme M, Shahinian AH, Banding JR, Conti PS (2004b) MicroPET and autoradiographic imaging of CRP receptor expression with 64Cu-DOTA-[Lys3]bombesin in human prostate adenocarcinoma xenografts. J Nucl Med 45:1390\u20131397","journal-title":"J Nucl Med"},{"key":"439_CR9","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1021\/bc0300403","volume":"15","author":"X Chen","year":"2004","unstructured":"Chen X, Park R, Tohme M, Shahinian AH, Bading JR, Conti PS (2004c) MicroPET and autoradiographic imaging of breast cancer \u03b1v-integrin expression using 18F- and 64Cu-labeled RGD peptide. Bioconj Chem 15:41\u201349","journal-title":"Bioconj Chem"},{"key":"439_CR10","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1162\/1535350041464892","volume":"3","author":"X Chen","year":"2004","unstructured":"Chen X, Tohme M, Park R, Hou Y, Bading JR, Conti PS (2004d) MicroPET imaging of breast cancer \u03b1v-integrin expression with 18F-labeled dimeric RGD peptide. Mol Imaging 3:96\u2013104","journal-title":"Mol Imaging"},{"key":"439_CR11","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1007\/s00259-006-0356-3","volume":"34","author":"M Visser de","year":"2007","unstructured":"de Visser M, Bernard HF, Erion JL, Schmidt MA, Srinivasan A, Waser B, Reubi JC, Krenning EP, de Jong M (2007) Novel 111In-labelled bombesin analogues for molecular imaging of prostate tumors. Eur J Nucl Med Mol Imaging 34:1228\u20131238","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"439_CR12","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.nucmedbio.2006.09.001","volume":"33","author":"C Decristoforo","year":"2006","unstructured":"Decristoforo C, Faintuch-Linkowski B, Rey A, von Guggenberg E, Rupprich M, Hernandez-Gonzales I, Rodrigo T, Haubner R (2006) [99mTc]HYNIC-RGD for imaging integrin \u03b1v\u03b23 expression. Nucl Med Biol 33:945\u2013952","journal-title":"Nucl Med Biol"},{"key":"439_CR13","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s00259-006-0180-9","volume":"34","author":"I Dijkgraaf","year":"2007","unstructured":"Dijkgraaf I, Kruijtzer JAW, Liu S, Soede A, Oyen WJG, Corstens FHM, Liskamp RMJ, Boerman OC (2007a) Improved targeting of the \u03b1v\u03b23 integrin by multimerization of RGD peptides. Eur J Nucl Med Mol Imaging 34:267\u2013273","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"439_CR14","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.nucmedbio.2006.10.006","volume":"34","author":"I Dijkgraaf","year":"2007","unstructured":"Dijkgraaf I, Liu S, Kruijtzer JAW, Soede AC, Oyen WJG, Liskamp RMJ, Corstens FHM, Boerman OC (2007b) Effect of linker variation on the in vitro and in vivo characteristics of an 111In-labeled RGD peptide. Nucl Med Biol 34:29\u201335","journal-title":"Nucl Med Biol"},{"key":"439_CR15","first-page":"1061","volume":"40","author":"R Haubner","year":"1999","unstructured":"Haubner R, Wester HJ, Reuning U, Senekowisch-Schmidtke R, Diefenbach B, Kessler H, St\u00f6cklin G, Schwaiger M (1999) Radiolabeled \u03b1v\u03b23 integrin antagonists: a new class of tracers for tumor imaging. J Nucl Med 40:1061\u20131071","journal-title":"J Nucl Med"},{"key":"439_CR16","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1002\/(SICI)1521-3765(19990702)5:7<1974::AID-CHEM1974>3.0.CO;2-X","volume":"5","author":"A Heppeler","year":"1999","unstructured":"Heppeler A, Froidevaux S, M\u00e4cke HR, Jermann E, B\u00e9h\u00e9 M, Powell P, Hennig M (1999) Radiometal-labelled macrocyclic chelator-derivatised somatostatin analogue with superb tumour targeting properties and potential for receptor-mediated internal radiotherapy. Chem Eur J 5:1974\u20131981","journal-title":"Chem Eur J"},{"key":"439_CR17","first-page":"6146","volume":"62","author":"ML Janssen","year":"2002","unstructured":"Janssen ML, Oyen WJG, Dijkgraaf I, Massuger LF, Frielink C, Edwards DS, Rajopadhye M, Boonstra H, Corstens FH, Boerman OC (2002) Tumor targeting with radiolabeled \u03b1v\u03b23 integrin binding peptides in a nude mouse model. Cancer Res 62:6146\u20136151","journal-title":"Cancer Res"},{"key":"439_CR18","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1021\/bc060055b","volume":"17","author":"B Jia","year":"2006","unstructured":"Jia B, Shi J, Yang Z, Xu B, Liu Z, Zhao H, Liu S, Wang F (2006) 99mTc-labeled cyclic RGDfK dimer: initial evaluation for SPECT imaging of glioma integrin \u03b1v\u03b23 expression. Bioconj Chem 17:1069\u20131076","journal-title":"Bioconj Chem"},{"key":"439_CR19","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1021\/bc7002988","volume":"19","author":"B Jia","year":"2008","unstructured":"Jia B, Liu Z, Shi J, Yu ZL, Yang Z, Zhao HY, He ZJ, Liu S, Wang F (2008) Linker effects on biological properties of 111In-labeled DTPA conjugates of a cyclic RGDfK dimer. Bioconj Chem 19:201\u2013210","journal-title":"Bioconj Chem"},{"key":"439_CR20","doi-asserted-by":"crossref","first-page":"879","DOI":"10.2967\/jnumed.107.049452","volume":"49","author":"LM Kenny","year":"2008","unstructured":"Kenny LM, Coombes RC, Oulie I, Contractor KB, Miller M, Spinks TJ, McParland B, Cohen PS, Hui A, Palmieri C, Osman S, Glaser M, Turton D, Al-Nahhas A, Aboagye EO (2008) Phase I trial of the positron-emitting Arg-Gly-Asp (RGD) peptide radioligand 18F-AH111585 in breast cancer patients. J Nucl Med 49:879\u2013886","journal-title":"J Nucl Med"},{"key":"439_CR21","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1007\/s00259-005-0006-1","volume":"33","author":"S Koukouraki","year":"2006","unstructured":"Koukouraki S, Strauss LG, Georgoulias V, Schuhmacher J, Haberkorn U, Karkavitsas N, Dimitrakopoulou-Strauss A (2006) Evaluation of the pharmacokinetics of 68Ga-DOTATOC in patients with metastatic neuroendocrine tumours scheduled for 90Y-DOTATOC therapy. Eur J Nucl Med Mol Imaging 33:460\u2013466","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"439_CR22","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/S1536-1632(03)00038-6","volume":"5","author":"J Kowalski","year":"2003","unstructured":"Kowalski J, Henze M, Schuhmacher J, Macke HR, Hofmann M, Haberkorn U (2003) Evaluation of positron emission tomography imaging using 68Ga-DOTA-D-Phe1-Tyr3-octreotide in comparison to 111In-DTPAOC SPECT. First results in patients with neuroendocrine tumors. Mol Imaging Biol 5:42\u201348","journal-title":"Mol Imaging Biol"},{"key":"439_CR23","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1200\/JCO.2007.15.2553","volume":"26","author":"DJ Kwekkeboom","year":"2008","unstructured":"Kwekkeboom DJ, de Herder WW, Kam BL, van Eijck CK, van Essen M, Kooij PP, Feelders RA, van Aken MO, Krenning EP (2008) Treatment with the radiolabeled somatostatin analog [177Lu-DOTA0, Tyr3]octreotate: toxicity, efficacy and survival. J Clin Oncol 26:2114\u20132130","journal-title":"J Clin Oncol"},{"key":"439_CR24","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1039\/b309961j","volume":"33","author":"S Liu","year":"2004","unstructured":"Liu S (2004) The role of coordination chemistry in development of target-specific radiopharmaceuticals. Chem Soc Rev 33:445\u2013461","journal-title":"Chem Soc Rev"},{"key":"439_CR25","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1021\/mp060049x","volume":"3","author":"S Liu","year":"2006","unstructured":"Liu S (2006) Radiolabeled multimeric cyclic RGD peptides as integrin \u03b1v\u03b23-targeted radiotracers for tumor imaging. Mol Pharm 3:472\u2013487","journal-title":"Mol Pharm"},{"key":"439_CR26","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1016\/j.addr.2008.04.006","volume":"60","author":"S Liu","year":"2008","unstructured":"Liu S (2008) Bifunctional coupling agents for radiolabeling of biomolecules and target-specific delivery of metallic radionuclides. Adv Drug Deliv Rev 60:1347\u20131370","journal-title":"Adv Drug Deliv Rev"},{"key":"439_CR27","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1021\/bc000070v","volume":"12","author":"S Liu","year":"2001","unstructured":"Liu S, Edwards DS (2001a) Bifunctional chelators for therapeutic lanthanide radiopharmaceuticals. Bioconj Chem 12:7\u201334","journal-title":"Bioconj Chem"},{"key":"439_CR28","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1021\/bc010013h","volume":"12","author":"S Liu","year":"2001","unstructured":"Liu S, Edwards DS (2001b) Synthesis and characterization of two 111In-labeled DTPA-peptide conjugates. Bioconj Chem 12:630\u2013634","journal-title":"Bioconj Chem"},{"key":"439_CR29","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1021\/bc000146n","volume":"12","author":"S Liu","year":"2001","unstructured":"Liu S, Cheung E, Rajopadyhe M, Ziegler MC, Edwards DS (2001a) 90Y- and 177Lu-labeling of a DOTA conjugated vitronectin receptor antagonist for tumor therapy. Bioconj Chem 12:559\u2013568","journal-title":"Bioconj Chem"},{"key":"439_CR30","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1021\/bc010012p","volume":"12","author":"S Liu","year":"2001","unstructured":"Liu S, Edwards DS, Ziegler MC, Harris AR, Hemingway SJ, Barrett JA (2001b) 99mTc-labeling of a hydrazinonictotinamide-conjugated vitronectin receptor antagonist. Bioconj Chem 12:624\u2013629","journal-title":"Bioconj Chem"},{"key":"439_CR31","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1358\/dof.2003.028.06.740860","volume":"28","author":"S Liu","year":"2003","unstructured":"Liu S, Robinson SP, Edwards DS (2003) Integrin \u03b1v\u03b23 directed radiopharmaceuticals for tumor imaging. Drugs Future 28:551\u2013564","journal-title":"Drugs Future"},{"key":"439_CR32","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1021\/bc0603081","volume":"18","author":"S Liu","year":"2007","unstructured":"Liu S, Hsieh WY, Jiang Y, Kim YS, Sreerama SG, Chen X, Jia B, Wang F (2007) Evaluation of a 99mTc-labeled cyclic RGD tetramer for non-invasive imaging integrin \u03b1v\u03b23-positive breast cancer. Bioconj Chem 18:438\u2013446","journal-title":"Bioconj Chem"},{"key":"439_CR33","doi-asserted-by":"crossref","first-page":"2985","DOI":"10.1021\/jm0490282","volume":"48","author":"P McQuade","year":"2005","unstructured":"McQuade P, Miao Y, Yoo J, Quinn TP, Welch MJ, Lewis JS (2005) Imaging of melanoma using 64Cu- and 86Y-DOTA-ReCCMSH(Arg11), a cyclized peptide analogue of \u03b1-MSH. J Med Chem 48:2985\u20132992","journal-title":"J Med Chem"},{"key":"439_CR34","doi-asserted-by":"crossref","first-page":"7980","DOI":"10.1021\/jm801134k","volume":"51","author":"J Shi","year":"2008","unstructured":"Shi J, Wang L, Kim YS, Zhai S, Liu Z, Chen X, Liu S (2008) Improving tumor uptake and excretion kinetics of 99mTc-labeled cyclic arginine-glycine-aspartic (RGD) dimers with triglycine linkers. J Med Chem 51:7980\u20137990","journal-title":"J Med Chem"},{"key":"439_CR35","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1021\/bc800455p","volume":"20","author":"J Shi","year":"2009","unstructured":"Shi J, Wang L, Kim YS, Zhai S, Liu Z, Chen X, Liu S (2009) Improving tumor uptake and pharmacokinetics of 64Cu-labeled cyclic RGD dimers with triglycine and PEG4 linkers. Bioconj Chem 20:750\u2013759","journal-title":"Bioconj Chem"},{"key":"439_CR36","first-page":"5237","volume":"60","author":"PA Smith-Jones","year":"2000","unstructured":"Smith-Jones PA, Vallabahajosula S, Goldsmith SJ, Navarro V, Hunter CJ, Bastidas D, Bander NH (2000) In vitro characterization of radiolabeled monoclonal antibodies specific for the extracellular domain of prostate specific membrane antigen. Cancer Res 60:5237\u20135243","journal-title":"Cancer Res"},{"key":"439_CR37","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0969-8051(97)00151-0","volume":"25","author":"JB Stimmel","year":"1998","unstructured":"Stimmel JB, Kull FC Jr (1998) Samarium-153 and lutetium-177 chelation properties of selected macrocyclic and cyclic ligands. Nucl Med Biol 25:117\u2013125","journal-title":"Nucl Med Biol"},{"key":"439_CR38","doi-asserted-by":"crossref","first-page":"2717","DOI":"10.1002\/chem.200204304","volume":"9","author":"G Thumshirn","year":"2003","unstructured":"Thumshirn G, Hersel U, Goodman SL, Kessler H (2003) Multimeric cyclic RGD peptides as potential tools for tumor targeting: solid-phase peptide synthesis and chemoselective oxime ligation. Chem Eur J 9:2717\u20132725","journal-title":"Chem Eur J"},{"key":"439_CR39","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1021\/mp800150r","volume":"6","author":"L Wang","year":"2009","unstructured":"Wang L, Kim YS, Shi J, Zhai S, Jia B, Liu Z, Zhao H, Wang F, Chen X, Liu S (2009) Improving tumor targeting capability and pharmacokinetics of 99mTc-labeled cyclic RGD dimers with PEG4 linkers. Mol Pharm 6:231\u2013245","journal-title":"Mol Pharm"},{"key":"439_CR40","first-page":"179","volume":"45","author":"WA Weber","year":"2001","unstructured":"Weber WA, Haubner R, Vabuliene E, Kuhnast B, Webster HJ, Schwaiger M (2001) Tumor angiogenesis targeting using imaging agents. Q J Nucl Med 45:179\u2013182","journal-title":"Q J Nucl Med"},{"key":"439_CR41","first-page":"1707","volume":"46","author":"Y Wu","year":"2005","unstructured":"Wu Y, Zhang X, Xiong Z, Cheng Z, Fisher DR, Liu S, Gambhir SS, Chen X (2005) MicroPET imaging of glioma integrin \u03b1v\u03b23 expression using 64Cu-labeled tetrameric RGD peptide. J Nucl Med 46:1707\u20131718","journal-title":"J Nucl Med"},{"key":"439_CR42","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1007\/s00259-007-0427-0","volume":"34","author":"Z Wu","year":"2007","unstructured":"Wu Z, Li Z, Cai W, He L, Chin FT, Li F, Chen X (2007a) 18F-labeled mini-PEG spacered RGD dimmer (18FPRGD2): synthesis and micro-PET imaging \u03b1v\u03b23 integrin expression. Eur J Nucl Med Mol Imaging 34:1823\u20131831","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"439_CR43","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.2967\/jnumed.107.040816","volume":"48","author":"Z Wu","year":"2007","unstructured":"Wu Z, Li Z, Chen K, Cai W, He L, Chin FT, Li F, Chen X (2007b) Micro-PET of tumor integrin \u03b1v\u03b23 expression using 18F-labeled PEGylated tetrameric RGD peptide (18F-FPRGD4). J Nucl Med 48:1536\u20131544","journal-title":"J Nucl Med"}],"container-title":["Amino Acids"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00726-009-0439-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00726-009-0439-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00726-009-0439-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T05:40:46Z","timestamp":1559108446000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00726-009-0439-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,1,6]]},"references-count":43,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2011,11]]}},"alternative-id":["439"],"URL":"https:\/\/doi.org\/10.1007\/s00726-009-0439-0","relation":{},"ISSN":["0939-4451","1438-2199"],"issn-type":[{"value":"0939-4451","type":"print"},{"value":"1438-2199","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,1,6]]}}}